Ubiratan F Machado Selected Research

NF-kappa B p50 Subunit

1/2018

Advanced glycation end products-induced insulin resistance involves repression of skeletal muscle GLUT4 expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ubiratan F Machado Research Topics

Disease

19	Insulin Resistance 01/2021 - 09/2002
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 01/2018
4	Inflammation (Inflammations) 01/2020 - 03/2010
4	Diabetes Mellitus 01/2020 - 11/2013
4	Type 2 Diabetes Mellitus (MODY) 01/2019 - 02/2013
4	Body Weight (Weight, Body) 01/2017 - 10/2003
3	Obesity 07/2013 - 09/2002
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2021
2	Kidney Diseases (Kidney Disease) 01/2020 - 01/2016
2	Atherosclerosis 01/2018 - 06/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2013 - 08/2012
1	Atherosclerotic Plaque (Atheroma) 01/2022
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Hyperglycemia 01/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2020
1	Diabetes Complications 01/2020
1	Body Weight Changes 01/2018
1	Glycosuria 01/2018
1	Weight Gain 02/2016
1	Fibrosis (Cirrhosis) 01/2016
1	Diabetic Nephropathies (Diabetic Nephropathy) 07/2013
1	Hypertension (High Blood Pressure) 04/2011
1	Albuminuria 04/2011
1	Hypersensitivity (Allergy) 06/2007
1	Hypoxia (Hypoxemia) 08/2005

Drug/Important Bio-Agent (IBA)

13	Insulin (Novolin)FDA Link 01/2018 - 09/2002
10	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 10/2003
5	Advanced Glycation End ProductsIBA 01/2022 - 06/2015
5	Messenger RNA (mRNA)IBA 01/2018 - 10/2003
4	CholesterolIBA 01/2022 - 03/2010
4	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2019 - 03/2010
4	Glucose Transporter Type 4IBA 12/2018 - 09/2002
4	AlbuminsIBA 01/2018 - 07/2013
3	LipidsIBA 12/2018 - 06/2015
3	Sodium Glutamate (Accent)IBA 08/2012 - 09/2002
2	Receptor for Advanced Glycation End ProductsIBA 01/2022 - 01/2018
2	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2018
2	Triglycerides (Triacylglycerol)IBA 01/2018 - 03/2010
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 03/2010
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 10/2003
2	Dietary Advanced Glycation End ProductsIBA 01/2018 - 01/2016
2	FructosamineIBA 01/2018 - 07/2017
2	Blood Glucose (Blood Sugar)IBA 01/2018 - 02/2016
2	Interleukin-6 (Interleukin 6)IBA 02/2013 - 03/2010
1	SterolsIBA 01/2022
1	25-hydroxycholesterolIBA 01/2022
1	24-hydroxycholesterolIBA 01/2022
1	27-hydroxycholesterolIBA 01/2022
1	OxysterolsIBA 01/2022
1	SodiumIBA 01/2021
1	Dietary SodiumIBA 01/2021
1	Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA 01/2020
1	LeukotrienesIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Estradiol (Delestrogen)FDA LinkGeneric 12/2018
1	NF-kappa B p50 SubunitIBA 01/2018
1	Angiotensin Receptor AntagonistsIBA 01/2018
1	Sirtuin 1IBA 01/2018
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2018
1	beta-Aminoethyl Isothiourea (AET)IBA 01/2018
1	Estrogens (Estrogen)FDA Link 10/2017
1	Pyruvic Acid (Pyruvate)IBA 07/2017
1	GlycogenIBA 01/2017
1	Liver GlycogenIBA 01/2017
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2017
1	Thiobarbituric Acid Reactive SubstancesIBA 01/2017
1	Drinking WaterIBA 02/2016
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 01/2016
1	N(6)-carboxymethyllysine (carboxymethyllysine)IBA 01/2016
1	ImmunosorbentsIBA 07/2013
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 07/2013
1	EnzymesIBA 07/2013
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2013
1	Ramipril (Altace)FDA LinkGeneric 07/2013
1	Amlodipine (Norvasc)FDA LinkGeneric 07/2013
1	CytokinesIBA 02/2013
1	QuercetinIBA 08/2012
1	FlavonoidsIBA 08/2012
1	salicylhydroxamic acid (SHAM)IBA 04/2011
1	InterleukinsIBA 03/2010
1	Interleukin-1beta (Interleukin 1 beta)IBA 03/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2010
1	Atorvastatin (Lipitor)FDA Link 03/2010
1	AdiponectinIBA 03/2010
1	Phosphotransferases (Kinase)IBA 03/2010
1	I-kappa B KinaseIBA 03/2010
1	Caveolin 1IBA 01/2006
1	Estrogen Receptor alphaIBA 01/2006
1	NF-kappa B (NF-kB)IBA 08/2005
1	MelatoninIBA 10/2003

Therapy/Procedure

2	Therapeutics 01/2018 - 07/2013
1	Carotid Endarterectomy 01/2022
1	Glycemic Control 01/2020
1	Aftercare (After-Treatment) 07/2013
1	Denervation 04/2011
1	Pinealectomy 10/2003